Home / Research and experimental development on biotechnology (except medical and veterinary science)

GENSCI SINGAPORE PTE. LTD.

Live CompanyUEN 202409669MLocal Company

GENSCI SINGAPORE PTE. LTD. is a local company in Singapore with UEN 202409669M. It was registered on 12 Mar 2024, 2 years ago. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202409669M
StatusLive Company
Entity typeLocal Company, Private Company Limited by Shares
Registered12 Mar 2024
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity47729 Retail sale of pharmaceutical and medical goods n.e.c.
Address2 JURONG EAST STREET 21, #04-18A, IMM BUILDING, Singapore 609601
770 companies at this address
AreaJurong East · District 22 (Jurong)
Nearest stationJurong East MRT, about 517 m
Officers8
Last annual return22 May 2026

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.